Media formats available:
Recommended
- Redefining intensive LDL-c management in high CV risk patients - The case for combination therapyExpanding therapeutic options for LDL-c lowering
Prof. Christie Ballantyne, MD
- Redefining intensive LDL-c management in high CV risk patients - The case for combination therapyCombination therapy with PCSK9 mAbs in post-MI patients
Derek Connolly, MD, PhD